Top

Published in:

Open Access 01-12-2022 | Opioids | Study protocol

Eating, Sleeping, Consoling for Neonatal Opioid Withdrawal (ESC-NOW): a Function-Based Assessment and Management Approach study protocol for a multi-center, stepped-wedge randomized controlled trial

Authors: Leslie W. Young, Songthip Ounpraseuth, Stephanie L. Merhar, Alan E. Simon, Abhik Das, Rachel G. Greenberg, Rosemary D. Higgins, Jeannette Lee, Brenda B. Poindexter, P. Brian Smith, Michele Walsh, Jessica Snowden, Lori A. Devlin, for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network and the NIH Environmental influences on Child Health Outcomes (ECHO) Program Institutional Development Awards States Pediatric Clinical Trials Network

Published in: Trials | Issue 1/2022

Excerpt

Increased opioid use has resulted in a dramatic increase in the number of infants born with in utero opioid exposure requiring management for NOWS [1‐4]. Despite the significance of this problem, numerous critical gaps remain in our knowledge with respect to the best practices for identification and management of infants with NOWS, as well as our understanding of the outcomes of these infants [5, 6]. The opioid epidemic particularly impacts rural and underserved communities represented by the ISPCTN and participating Neonatal Research Network (NRN) sites, which makes our networks well poised to address these critical gaps and improve the care of infants with NOWS. …

Available only for authorised users

Patrick SW, Davis MM, Lehman CU, Cooper WO. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. J Perinatol. 2015;35(8):667.PubMedCrossRef

Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA. 2012;307(18):1934–40.PubMedCrossRef

Tolia VN, Patrick SW, Bennett MM, Murthy K, Sousa J, Smith PB, et al. Increasing incidence of the neonatal abstinence syndrome in U.S. neonatal ICUs. New Engl J Med. 2015;372(22):2118–26.PubMedCrossRef

Hudak ML, Tan RC, Committee On D, Committee On F, Newborn, American Academy of P. Neonatal drug withdrawal. Pediatrics. 2012;129(2):e540–60.PubMedCrossRef

Reddy UM, Davis JM, Ren Z, Greene MF. Opioid Use in Pregnancy NAS, Childhood Outcomes Workshop Invited S. Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes: Executive Summary of a Joint Workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal-Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes Foundation. Obstet Gynecol. 2017;130(1):10–28.PubMedPubMedCentralCrossRef

U.S. Government Accountability Office. Newborn health: Federal action needed to address Neonatal Abstinence Syndrome. 2017. Available from: https://www.gao.gov/products/gao-18-32. Accessed 25 Sept 2017.

Centers for Disease Control and Prevention. Vital Signs: prescription painkiller overdoses: a growing epidemic, especially among women. 2016. Available from: http://www.cdc.gov/vitalsigns/prescriptionpainkilleroverdoses/. Accessed 25 Sept 2017.

International Narcotics Control Board. Report of the International Narcotics Control Board for 2010. 2010. Available from: https://www.incb.org/documents/Publications/AnnualReports/AR2010/AR_2010_English.pdf. Accessed 25 Sept 2017.

Ailes EC, Dawson AL, Lind JN, Gilboa SM, Frey MT, Broussard CS, et al. Opioid prescription claims among women of reproductive age--United States, 2008-2012. MMWR. 2015;64(2):37–41. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6402a1.htm. Accessed 25 Sept 2017.

10.

O'Donnell JK, Gladden RM, Seth P. Trends in Deaths Involving Heroin and Synthetic Opioids Excluding Methadone, and Law Enforcement Drug Product Reports, by Census Region - United States, 2006-2015. MMWR Morb Mortal Wkly Rep. 2017;66(34):897–903.PubMedPubMedCentralCrossRef

11.

Haight SC, Ko JY, Tong VT, Bohm MK, Callaghan WM. Opioid Use Disorder Documented at Delivery Hospitalization - United States, 1999-2014. MMWR Morb Mortal Wkly Rep. 2018;67(31):845–9.PubMedPubMedCentralCrossRef

12.

Agency for Healthcare Research and Quality. Health Care Cost and Utilization Project (HCUP). 2018. Available from: https://www.ahrq.gov/data/hcup/index.html. Accessed 2 Oct 2018.

13.

Winkelman TNA, Villapiano N, Kozhimannil KB, Davis MM, Patrick SW. Incidence and Costs of Neonatal Abstinence Syndrome Among Infants With Medicaid: 2004-2014. Pediatrics. 2018, 141(4):e20173520.

14.

Milliren CE, Gupta M, Graham DA, Melvin P, Jorina M, Ozonoff A. Hospital Variation in Neonatal Abstinence Syndrome Incidence, Treatment Modalities, Resource Use, and Costs Across Pediatric Hospitals in the United States, 2013 to 2016. Hosp Pediatr. 2018;8(1):15–20.PubMedCrossRef

15.

Patrick SW, Faherty LJ, Dick AW, Scott TA, Dudley J, Stein BD. Association Among County-Level Economic Factors, Clinician Supply, Metropolitan or Rural Location, and Neonatal Abstinence Syndrome. JAMA. 2019;321(4):385–93.PubMedPubMedCentralCrossRef

16.

Villapiano NL, Winkelman TN, Kozhimannil KB, Davis MM, Patrick SW. Rural and Urban Differences in Neonatal Abstinence Syndrome and Maternal Opioid Use, 2004 to 2013. JAMA Pediatr. 2017;171(2):194–6.PubMedCrossRef

17.

Kraft WK, Stover MW, Davis JM. Neonatal abstinence syndrome: Pharmacologic strategies for the mother and infant. Semin Perinatol. 2016;40(3):203–12.PubMedPubMedCentralCrossRef

18.

Gomez Pomar E, Finnegan LP, Devlin L, Bada H, Concina VA, Ibonia KT, et al. Simplification of the Finnegan Neonatal Abstinence Scoring System: retrospective study of two institutions in the USA. BMJ Open. 2017;7(9):e016176.PubMedPubMedCentralCrossRef

19.

Jones HE, Seashore C, Johnson E, Horton E, O'Grady KE, Andringa K, et al. Psychometric assessment of the Neonatal Abstinence Scoring System and the MOTHER NAS Scale. Am J Addict. 2016;25(5):370–3.PubMedCrossRef

20.

Mehta A, Forbes KD, Kuppala VS. Neonatal Abstinence Syndrome Management From Prenatal Counseling to Postdischarge Follow-up Care: Results of a National Survey. Hosp Pediatr. 2013;3(4):317–23.PubMedCrossRef

21.

Zimmermann-Baer U, Notzli U, Rentsch K, Bucher HU. Finnegan neonatal abstinence scoring system: normal values for first 3 days and weeks 5-6 in non-addicted infants. Addiction. 2010;105(3):524–8.PubMedCrossRef

22.

Maguire D, Cline GJ, Parnell L, Tai CY. Validation of the Finnegan neonatal abstinence syndrome tool-short form. Adv Neonatal Care. 2013;13(6):430–7.PubMedCrossRef

23.

Jansson LM, Velez M, Harrow C. The opioid-exposed newborn: assessment and pharmacologic management. J Opioid Manag. 2009;5(1):47–55.PubMedPubMedCentralCrossRef

24.

Timpson W, Killoran C, Maranda L, Picarillo A, Bloch-Salisbury E. A Quality Improvement Initiative to Increase Scoring Consistency and Accuracy of the Finnegan Tool: Challenges in Obtaining Reliable Assessments of Drug Withdrawal in Neonatal Abstinence Syndrome. Adv Neonatal Care. 2018;18(1):70–8.PubMedPubMedCentralCrossRef

25.

Grossman MR, Berkwitt AK, Osborn RR, Xu Y, Esserman DA, Shapiro ED, et al. An Initiative to Improve the Quality of Care of Infants With Neonatal Abstinence Syndrome. Pediatrics. 2017;139(6):e20163360.PubMedCrossRef

26.

Grossman MR, Lipshaw MJ, Osborn RR, Berkwitt AK. A Novel Approach to Assessing Infants With Neonatal Abstinence Syndrome. Hosp Pediatr. 2018;8(1):1–6.PubMedCrossRef

27.

Whalen GL, Grossman MR, Whatley C. Inter- and intra-rater reliability of the Eating, Sleeping, Consoling (ESC) care tool for Neonatal Abstinence Syndrome (NAS). In Proceedings from the 2018 Annual Meeting of the Pediatric Academic Societies 2018 May 5.

28.

Wachman EM, Grossman M, Schiff DM, Philipp BL, Minear S, Hutton E, et al. Quality improvement initiative to improve inpatient outcomes for Neonatal Abstinence Syndrome. J Perinatol. 2018;38:1114.PubMedCrossRef

29.

Wachman EM, Schiff DM, Silverstein M. Neonatal Abstinence Syndrome: Advances in Diagnosis and Treatment. JAMA. 2018;319(13):1362–74.PubMedCrossRef

30.

Holmes AV, Atwood EC, Whalen B, Beliveau J, Jarvis JD, Matulis JC, et al. Rooming-In to Treat Neonatal Abstinence Syndrome: Improved Family-Centered Care at Lower Cost. Pediatrics. 2016;137(6).

31.

McKnight S, Coo H, Davies G, Holmes B, Newman A, Newton L, et al. Rooming-in for Infants at Risk of Neonatal Abstinence Syndrome. Am J Perinatol. 2016;33(5):495–501.PubMedCrossRef

32.

Ko JY, Patrick SW, Tong VT, Patel R, Lind JN, Barfield WD. Incidence of Neonatal Abstinence Syndrome - 28 States, 1999-2013. MMWR Morb Mortal Wkly Rep. 2016;65(31):799–802.PubMedCrossRef

33.

MacMillan K, Whalen BL, Flanagan V, Chen S, Harris KR, Swasey E, et al. Understanding Family Perspectives: A Follow-Up Qualitative Study of Family Experience with Hospitalization for Neonatal Abstinence Syndrome. Toronto: Platform presentation: Pediatric Academic Society Meeting; 2018.

34.

Brown MS, Hayes MJ, Thornton LM. Methadone versus morphine for treatment of neonatal abstinence syndrome: a prospective randomized clinical trial. J Perinatol. 2015;35(4):278–83.PubMedCrossRef

35.

Davis JM, Shenberger J, Terrin N, Breeze JL, Hudak M, Wachman EM, et al. Comparison of Safety and Efficacy of Methadone vs Morphine for Treatment of Neonatal Abstinence Syndrome: A Randomized Clinical Trial. JAMA Pediatr. 2018;172:741.PubMedPubMedCentralCrossRef

36.

Kraft WK, Adeniyi-Jones SC, Chervoneva I, Greenspan JS, Abatemarco D, Kaltenbach K, et al. Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome. New Engl J Med. 2017;376(24):2341–8.PubMedCrossRef

37.

McRae AD, Weijer C, Binik A, Grimshaw JM, Boruch R, Brehaut JC, et al. When is informed consent required in cluster randomized trials in health research? Trials. 2011;12:202.PubMedPubMedCentralCrossRef

38.

Abdel-Latif ME, Pinner J, Clews S, Cooke F, Lui K, Oei J. Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics. 2006;117(6):e1163–9.PubMedCrossRef

39.

McQueen KA, Murphy-Oikonen J, Gerlach K, Montelpare W. The impact of infant feeding method on neonatal abstinence scores of methadone-exposed infants. Adv Neonatal Care. 2011;11(4):282–90.PubMedCrossRef

40.

Gartstein MAR, M.K. Studying infant temperament via the Revised Infant Behavior Questionnaire. Infant Behav Dev. 2003;26:64–86.CrossRef

41.

Bosquet Enlow M, White MT, Hails K, Cabrera I, Wright RJ. The Infant Behavior Questionnaire-Revised: Factor structure in a culturally and sociodemographically diverse sample in the United States. Infant Behav Dev. 2016;43:24–35.PubMedCrossRef

42.

Gartstein MA, Marmion J. Fear and positive affectivity in infancy: convergence/discrepancy between parent-report and laboratory-based indicators. Infant Behav Dev. 2008;31(2):227–38.PubMedPubMedCentralCrossRef

43.

Goldsmith HH, Campos JJ. The structure of temperamental fear and pleasure in infants: a psychometric perspective. Child Dev. 1990;61(6):1944–64.PubMedCrossRef

44.

Parade SH, Leerkes EM. The reliability and validity of the Infant Behavior Questionnaire-Revised. Infant Behav Dev. 2008;31(4):637–46.PubMedPubMedCentralCrossRef

45.

Putnam SP, Helbig AL, Gartstein MA, Rothbart MK, Leerkes E. Development and assessment of short and very short forms of the infant behavior questionnaire-revised. J Pers Assess. 2014;96(4):445–58.PubMedCrossRef

46.

Sadeh A. A brief screening questionnaire for infant sleep problems: validation and findings for an Internet sample. Pediatrics. 2004;113(6):e570–7.PubMedCrossRef

47.

Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol. 2010;63(11):1179–94.PubMedPubMedCentralCrossRef

48.

Thomas KA, Spieker S. Sleep, Depression, and Fatigue in Late Postpartum. MCN Am J Matern Child Nurs. 2016;41(2):104–9.PubMedPubMedCentralCrossRef

49.

Busse M, Stromgren K, Thorngate L, Thomas KA. Parents' responses to stress in the neonatal intensive care unit. Crit Care Nurse. 2013;33(4):52–9 quiz 60.PubMedPubMedCentralCrossRef

50.

Condon JT, Corkindale CJ. The assessment of parent-to-infant attachment: Development of a self-report questionnaire instrument. J Reprod Infant Psychol. 1998;16(1):57–76.CrossRef

51.

Rossen L, Hutchinson D, Wilson J, Burns L, Olsson CA, Allsop S, et al. Predictors of postnatal mother-infant bonding: the role of antenatal bonding, maternal substance use and mental health. Arch Womens Ment Health. 2016;19(4):609–22.PubMedCrossRef

52.

Codon JTC, C.J. The assessment of parent-to-infant attachement: Development of a self-report questionnaire instrument. J Reprod Infant Psychol. 1998;16(1):57–76.CrossRef

53.

Brown S, Hicks LM, Tracy EM. Parenting Efficacy and Support in Mothers With Dual Disorders in a Substance Abuse Treatment Program. J Dual Diagn. 2016;12(3-4):227–37.PubMedPubMedCentralCrossRef

54.

Moos RHM, Moos BS. Family environment scale manual. Palo Alto: Consulting Psychologists Press; 1981. p. 38.

55.

Felitti VJ, Anda RF, Nordenberg D, Williamson DF, Spitz AM, Edwards V, et al. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) study. Am J Prev Med. 1998;14(4):245–58.PubMedCrossRef

56.

Albers CA, Grieve AJ. Review of Bayley Scales of Infant and Toddler Development - Third Edition. J Psychoeduc Assess [Internet]. 2007;25(2):180–90. Available from. https://doi.org/10.1177/0734282906297199.CrossRef

57.

Briggs-Gowan MJ, Carter AS, Irwin JR, Wachtel K, Cicchetti DV. The Brief Infant-Toddler Social and Emotional Assessment: screening for social-emotional problems and delays in competence. J Pediatr Psychol. 2004;29(2):143–55.PubMedCrossRef

58.

Gibbons LE, Feldman BJ, Crane HM, Mugavero M, Willig JH, Patrick D, et al. Migrating from a legacy fixed-format measure to CAT administration: calibrating the PHQ-9 to the PROMIS depression measures. Qual Life Res. 2011;20(9):1349–57.PubMedPubMedCentralCrossRef

59.

Pilkonis PA, Yu L, Dodds NE, Johnston KL, Maihoefer CC, Lawrence SM. Validation of the depression item bank from the Patient-Reported Outcomes Measurement Information System (PROMIS) in a three-month observational study. J Psychiatr Res. 2014;56:112–9.PubMedPubMedCentralCrossRef

60.

Xie T, Waksman J. Design and sample size estimation in clinical trials with clustered survival times as the primary endpoint. Stat Med. 2003;22(18):2835–46.PubMedCrossRef

61.

Rosner B, Glynn RJ, Lee ML. Incorporation of clustering effects for the Wilcoxon rank sum test: a large-sample approach. Biometrics. 2003;59(4):1089–98.PubMedCrossRef

62.

Lorenz DJ, Datta S, Harkema SJ. Marginal association measures for clustered data. Stat Med. 2011;30(27):3181–91.PubMedPubMedCentralCrossRef

63.

Grayling MJ, Wason JM, Mander AP. Stepped wedge cluster randomized controlled trial designs: a review of reporting quality and design features. Trials. 2017;18(1):33.PubMedPubMedCentralCrossRef

64.

Hemming K, Taljaard M, McKenzie JE, Hooper R, Copas A, Thompson JA, et al. Reporting of stepped wedge cluster randomised trials: extension of the CONSORT 2010 statement with explanation and elaboration. BMJ. 2018;363:k1614.PubMedPubMedCentralCrossRef

65.

Hooper R, Teerenstra S, de Hoop E, Eldridge S. Sample size calculation for stepped wedge and other longitudinal cluster randomised trials. Stat Med. 2016;35(26):4718–28.PubMedCrossRef

66.

Hussey MA, Hughes JP. Design and analysis of stepped wedge cluster randomized trials. Contemp Clin Trials. 2007;28(2):182–91.PubMedCrossRef

67.

McCullagh P, Nelder JA. Generalized linear models. 2nd ed. Boca Raton: Chapman & Hall/CRC; 1989. p. 532.CrossRef

68.

Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: L Erlbaum Associates; 1988. p. 567.

69.

Rosnow RLR, R. Computing contrasts, effect sizes, and counternulls on other people's published data: General procedures for research consumers. Psychological Methods. 1996;1(4):331–40.CrossRef

70.

Osborn DA, Jeffery HE, Cole MJ. Opiate treatment for opiate withdrawal in newborn infants. Cochrane Database Syst Rev. 2010;10:Cd002059.

71.

Gomez-Pomar E, Finnegan LP, Devlin L, Bada H, Concina VA, Ibonia KT, et al. Simplification of the Finnegan Neonatal Abstinence Scoring System: retrospective study of two institutions in the USA. BMJ Open. 2017;7:e016176. Available from. https://doi.org/10.1136/bmjopen-2017-016176.CrossRefPubMedPubMedCentral

72.

Merhar SL, Kline-Fath BM, Nathan AT, Melton KR, Bierbrauer KS. Identification and management of neonatal skull fractures. J Perinatol. 2016;36(8):640–2.PubMedCrossRef

73.

Loyal J, Pettker CM, Raab CA, O'Mara E, Lipkind HS. Newborn Falls in a Large Tertiary Academic Center Over 13 Years. Hosp Pediatr. 2018;8(9):509–14.PubMedCrossRef

74.

Maalouf FI, Cooper WO, Slaughter JC, Dudley J, Patrick SW. Outpatient pharmacotherapy for Neonatal Abstinence Syndrome. J Pediatr. 2018;199:151–157.e1. Available from. https://doi.org/10.1016/j.jpeds.2018.03.048.CrossRefPubMedPubMedCentral

Title: Eating, Sleeping, Consoling for Neonatal Opioid Withdrawal (ESC-NOW): a Function-Based Assessment and Management Approach study protocol for a multi-center, stepped-wedge randomized controlled trial
Authors: Leslie W. Young
Songthip Ounpraseuth
Stephanie L. Merhar
Alan E. Simon
Abhik Das
Rachel G. Greenberg
Rosemary D. Higgins
Jeannette Lee
Brenda B. Poindexter
P. Brian Smith
Michele Walsh
Jessica Snowden
Lori A. Devlin
for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network and the NIH Environmental influences on Child Health Outcomes (ECHO) Program Institutional Development Awards States Pediatric Clinical Trials Network
Publication date: 01-12-2022
Publisher: BioMed Central
Keywords: Opioids
Opioids
Published in: Trials / Issue 1/2022
Electronic ISSN: 1745-6215
DOI: https://doi.org/10.1186/s13063-022-06445-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Eating, Sleeping, Consoling for Neonatal Opioid Withdrawal (ESC-NOW): a Function-Based Assessment and Management Approach study protocol for a multi-center, stepped-wedge randomized controlled trial

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

A deprescribing medication program to evaluate falls in older adults: methods for a randomized pragmatic clinical trial

Effectiveness and adherence to closed face shields in the prevention of COVID-19 transmission: a non-inferiority randomized controlled trial in a middle-income setting (COVPROSHIELD)

Study protocol of a multiphase optimization strategy trial (MOST) for delivery of smoking cessation treatment in lung cancer screening settings

Protocol for a cluster randomized control trial of the impact of the Breaking the Man Code workshops on adolescent boys’ intentions to seek help

Update on the clinical trial landscape: analysis of ClinicalTrials.gov registration data, 2000–2020

Job retention vocational rehabilitation for employed people with inflammatory arthritis: adaptations to the WORKWELL trial due to the impact of the COVID-19 pandemic